AstraZeneca Asks Court Not to Revive Whistle-Blower Suit
This article is for subscribers only.
AstraZeneca Plc and Bristol-Myers Squibb Co. urged a Philadelphia federal appeals court not to revive a 10-year-old lawsuit alleging the drugmakers paid kickbacks to benefits manager Medco Health Solutions Inc.
A lower court in January dismissed the whistle-blower case brought by Karl Schumann, a former Medco employee, ruling that his allegations were based on public information and he failed to show he had direct and independent knowledge of a scheme. Schumann simply sat in meetings, the companies said, calling his lawsuit “parasitic” in court filings.